Skip to content
Recall Observatory FDA recall evidence

Drug product

Eptifibatide Injection, a) 20 mg/10 mL (2 mg/mL),10 mL Single Use Vial, NDC 17478-902-10, b) 200 mg/100 mL (2 mg/mL), 100 mL Single-use Vial, NDC 17478-902-90, For Intravenous Use Only, Rx Only, Manufactured by: Akorn Inc., Lake Forest, IL 60045.

D-1841-2019

August 06, 2019

Class III

Product summary

Firm
Akorn, Inc.
Event
Event 83497
Status
Terminated
Classification
Class III
Quantity
8187 vials
Official record key
drug-enforcement:D-1841-2019

Official wording

Reason: Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.

Code information: Lot #s: a) 091307A, Exp. 9/19; 101097A, Exp. 10/19; b) 091277A, Exp. 9/19.

Distribution pattern: Nationwide in the U.S.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out of Specification